| Deanne Elizabeth Kiba, DO, FAARFM | |
|
543 N Main St Ste 122, Rochester, MI 48307-1485 | |
| (248) 601-5055 | |
| (248) 659-1639 |
| Full Name | Deanne Elizabeth Kiba |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 543 N Main St Ste 122, Rochester, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508070475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 8892 (Ohio) | Secondary |
| 207Q00000X | Family Medicine | 3307946 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrative Family Care, Pllc | 5890028336 | 4 |
News Archive
Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die.
Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.
Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.
Research into Parkinson's Disease at the University of Dundee has received a boost from a fundraising campaign organised by the Falkirk Branch of the Parkinson's Disease Society.
› Verified 1 days ago
| Entity Name | Shelby Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326320599 PECOS PAC ID: 5597932525 Enrollment ID: O20120116000055 |
News Archive
Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die.
Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.
Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.
Research into Parkinson's Disease at the University of Dundee has received a boost from a fundraising campaign organised by the Falkirk Branch of the Parkinson's Disease Society.
› Verified 1 days ago
| Entity Name | Integrative Family Care, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225692387 PECOS PAC ID: 5890028336 Enrollment ID: O20190614001553 |
News Archive
Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die.
Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.
Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.
Research into Parkinson's Disease at the University of Dundee has received a boost from a fundraising campaign organised by the Falkirk Branch of the Parkinson's Disease Society.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deanne Elizabeth Kiba, DO, FAARFM 6436 Adams Dr, Washington Township, MI 48094-1238 Ph: (330) 988-2207 | Deanne Elizabeth Kiba, DO, FAARFM 543 N Main St Ste 122, Rochester, MI 48307-1485 Ph: (248) 601-5055 |
News Archive
Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die.
Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.
Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.
Research into Parkinson's Disease at the University of Dundee has received a boost from a fundraising campaign organised by the Falkirk Branch of the Parkinson's Disease Society.
› Verified 1 days ago
Dr. Umesh G Gowda, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-651-1155 Fax: 248-651-8537 | |
Jinping Xu, MD MS Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 W University Dr, Ste 250, Rochester, MI 48307 Phone: 248-650-6301 Fax: 248-650-5486 | |
Eleanor King, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, 3-north, Rochester, MI 48307 Phone: 248-601-4900 | |
Kevin Florek, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5813 Fax: 248-650-9160 | |
Tsveti Petrova Markova, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1135 W University Dr, Suite 250, Rochester, MI 48307 Phone: 248-650-6301 Fax: 248-650-5486 | |
Sheala Jafry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1135 W University Dr, Suite 250, Rochester, MI 48307 Phone: 248-650-6301 Fax: 248-650-5486 | |
John A Otremba, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1135 W University Dr, Suite 250, Rochester, MI 48307 Phone: 248-650-6301 Fax: 248-650-5486 |